Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Conduct a value comparison of no annual fee cash back cards to find the right one for your spending needs. Make informed choices.
25,387 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
SpaceX is inching toward a public listing that could expose who truly owns private stakes and how that ownership tran...
Gas costs are squeezing budgets as consumers cut back on dining out. Retailers feel the pull as higher fuel bills tak...
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...
Gen Z faces an AI-driven job market that keeps reshaping roles. This piece outlines adaptable skills and practical st...
The AI IPO wave is heating up, and Anthropic sits at the center. This guide explains how early backers could see wind...
Toyota Ventures and Apex are linking auto-racing discipline with satellite development, signaling new crossovers for ...
A coalition representing the crypto industry files a lawsuit to block Illinois' Digital Asset Tax Act, arguing the le...
XRP is gaining on-chain strength while price action remains muted, moving ahead of Solana in tokenized asset value an...
A widely followed crypto trader called Cardano ADA one of his worst investments, igniting a cross-community debate ab...
Ambiq Micro shares jumped as investors priced in stronger demand for ultra-low-power edge AI technology. This article...
Minnesota’s business elite issued a restrained message on immigration enforcement that drew sharp critique and raised...